SCHEMBL9765984

SCHEMBL9765984

Fc1ccc(CCCCN2CCN(c3ncc(F)cn3)CC2)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 8/20 1.00
HTR1A P08908 7/20 0.80
DRD2 P14416 6/20 0.80
HTR2A P28223 6/20 0.80
DRD3 P35462 6/20 0.80
DRD1 P21728 4/20 0.80
DRD5 P21918 4/20 0.80
DRD4 P21917 4/20 0.64
HTR7 P34969 3/20 0.64
HTR2C P28335 2/20 0.64
SLC6A4 P31645 2/20 0.64
TMEM97 Q5BJF2 2/20 0.64
KDM4E B2RXH2 1/20 0.63
CYP1A2 P05177 1/20 0.63
GAA P10253 1/20 0.63
CYP2C9 P11712 1/20 0.63
ADRA2C P18825 1/20 0.63
HRH1 P35367 1/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9766043 0.90 SIGMAR1 (0.82) SIGMAR1HTR1ADRD2HTR2ADRD3
SCHEMBL9766026 0.81 SIGMAR1 (1.00) SIGMAR1HTR1ADRD2HTR2ADRD3
SCHEMBL7521159 0.80 SIGMAR1 (0.66) SIGMAR1HTR1ADRD2KDM4ECYP1A2
SCHEMBL30350966 0.80 SIGMAR1 (0.66) SIGMAR1HTR1ADRD2KDM4ECYP1A2
SCHEMBL9766035 0.79 SIGMAR1 (0.65) SIGMAR1HTR1ADRD2HTR2ADRD3
SCHEMBL9602967 0.78 SIGMAR1 (0.79) SIGMAR1DRD2KDM4ECYP1A2GAA
SCHEMBL9765998 0.78 SIGMAR1 (1.00) SIGMAR1HTR1ADRD2HTR2ADRD3
SCHEMBL7855443 0.78 SIGMAR1 (0.63) SIGMAR1HTR1ADRD2KDM4ECYP1A2
SCHEMBL27236997 0.77 DRD3 (1.00) SIGMAR1HTR1ADRD2HTR2ADRD3
Bmy-14802 SCHEMBL8457738 0.77 SIGMAR1 (1.00) SIGMAR1DRD2DRD3KDM4ECYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0400661-A1 Agents for treatment of brain ischemia Bristol-Myers Squibb Company (US) 1990-12-05 EP claimed
US-4994460-A Treatment or prevention of disorders resulting from central nervous system anoxia BRISTOL-MYERS SQUIBB CO. (US) 1991-02-19 US disclosed
EP-0400661-A1 Agents for treatment of brain ischemia Bristol-Myers Squibb Company (US) 1990-12-05 EP disclosed